WCAS is the leading private equity investor in our two growth
industries of technology and healthcare. Our target industries are
very large and totaled approximately $7 trillion in 2014,
representing approximately 40% of U.S. GDP. We believe our
domain industry knowledge, developed over 37 years, dramatically
improves our ability to (i) source and close transactions, (ii)
conduct more effective due diligence, (iii) recruit seasoned
management teams, (iv) identify operating improvements, (v) capture
synergies across the portfolio and (vi) take advantage of
inefficiencies in the capital markets.
We utilize a top-down approach to sourcing and evaluating deals.
WCAS completes in-depth reviews of all the subsectors within
our two core industries; identifies potential acquisition
candidates; and focuses on ways to better source transactions to
build a strong deal pipeline.
WCAS is well known for creating leading companies within its
target industries. There are over 40 current or former public
companies in our two core industries that can trace their roots to
WCAS. The combined market capitalization of these companies exceeds
$150 billion. Examples of current or former WCAS technology
portfolio companies include (i) Alliance Data Systems Corporation
(ADS); (ii) Amdocs Limited (DOX); (iii) Bisys; (iv) Card
Establishment Services, which merged into First Data; (v) ComData,
which was acquired by Ceridian, and (vi) Fiserv, Inc. (FISV).
Examples of current or former WCAS healthcare companies include (i)
Accuro, which was acquired by MedAssets (MDAS); (ii) AGA Medical,
which was acquired by St. Jude Medical (STJ); (iii) Accredo Health,
which was acquired by Medco Health Solutions; (iv) AmeriPath and
LabOne, which were acquired by Quest Diagnostics (DGX); (v)
Magella, which was acquired by MEDNAX (MD); (vi) Quorum Health
Group Inc., which was merged into Triad Hospitals; (vii) Select
Medical Corporation (SEM) and (viii) US Oncology, which was
acquired by McKesson (MCK).